NEXENTIS TECHNOLOGIES INC. Impairment of Long-Lived Assets Held-for-use
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Impairment of Long-Lived Assets Held-for-use of -$36.70 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2022-03-31
- NEXENTIS TECHNOLOGIES INC. impairment of long-lived assets held-for-use for fiscal 2020 was -$36.70K.
- NEXENTIS TECHNOLOGIES INC. impairment of long-lived assets held-for-use for fiscal 2019 was -$36.70K.
- NEXENTIS TECHNOLOGIES INC. impairment of long-lived assets held-for-use for fiscal 2018 was -$36.70K.
| Period end | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|
| 2020-12-31 | -$36.70K 10-K · filed 2022-03-31 |
| 2019-12-31 | -$36.70K 10-K · filed 2021-03-29 |
| 2018-12-31 | -$36.70K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |